0001104659-22-103709.txt : 20220928 0001104659-22-103709.hdr.sgml : 20220928 20220928160557 ACCESSION NUMBER: 0001104659-22-103709 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220926 FILED AS OF DATE: 20220928 DATE AS OF CHANGE: 20220928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZACCARDELLI DAVID CENTRAL INDEX KEY: 0001627642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 221276094 MAIL ADDRESS: STREET 1: 300 TRI STATE INTERNATIONAL STREET 2: SUITE 272 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE 4 1 tm2226815-1_4seq.xml OWNERSHIP DOCUMENT X0306 4 2022-09-26 0 0001657312 Verona Pharma plc VRNA 0001627642 ZACCARDELLI DAVID 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE UNITED KINGDOM 1 1 0 0 President and CEO Ordinary Shares 2022-09-26 4 A 0 3600000 0 A 18863560 D Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. Represents an award of Restricted Share Units ("RSUs"), each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer. The RSUs vest over four years, with 900,000 RSUs vesting on November 1, 2023 and the balance vesting in 12 equal quarterly installments thereafter. Consists of (i) 10,702,720 Ordinary Shares underlying RSUs (which are represented by 1,337,840 ADSs); and (ii) 8,160,840 Ordinary Shares underlying 1,020,105 ADSs. /s/ Claire Poll, Attorney-in-fact for David Zaccardelli 2022-09-28